Kenya Infectious Disease Market Analysis


  • Type: Therapeutics Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4822

  • Format: PPT, PDF

Kenya Infectious Diseases Drug Market: Segmented by Diseases (Malaria, HIV/AIDS, Tuberculosis, Hepatis, Human Papilloma Virus (HPV), Acute Respiratory Infections, Diarrhoea, Cholera, Meningitis, Schistosomiasis and Other Applications), Drug Class (Anti-Infectives, Corticosteroids, Vaccine and Other Drug Classes), Causative agents (Bacteria, Virus, Fungi, Parasites and other) and Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 4822 Categories: ,

Report Overview

The Infectious diseases drug market size in Kenya stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Infectious diseases continue to be the major causes of mortality in Kenya. Well known existing, emerging and re-emerging diseases like malaria, tuberculosis, HIV/AIDS, cholera, meningitis, hepatitis, schistosomiasis, lymphatic filariasis, Ebola and SARS are causing suffering and deaths in Kenya. Infectious Diseases are caused by wide range of micro-organisms like bacteria, viruses, fungi and parasites and can cause mild to severe illnesses or even death. According to UNAIDS report 2019, there are about 1.5 million adults and children living with HIV in Kenya. Though the prevalence rate has declined from 5.9% in 2018-19 to 4.8% in  2019-20, infection rates among young people remain concerning. In 2019, the Kenya national malaria incidence was reported at 125.92 cases per 1000 population. The WHO African region is home to 94% of malaria cases and deaths. Risk factors for infectious diseases include poor sanitation and personal hygiene. Despite increased government initiatives to control infectious diseases like malaria, HIV and tuberculosis and vaccination programmes, situation remains a cause of concern in Kenya.

Market Drivers

The market is majorly driven by the largest share of the Global Disease burden of Infectious diseases in Africa. Increasing initiatives taken by the Government of Kenya and Non-Governmental Organizations (NGOs) like distribution of free generic medicines in high incidence areas, increasing awareness among population to curb the spread of infectious diseases like HIV and tuberculosis will boost the market growth.

Furthermore, entry of generic drugs in market that are cost-effective is expected to increase the demand in infectious disease therapeutics.

Rising funding for research and development and development of new drugs will drive growth in the infectious diseases therapeutic market.

However, low penetration rate of anti-infectives and availability of large number of counterfeit drugs are expected to restrict growth in the market.

1. Kenya Infectious Diseases Drug Market Overview……………………
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Growing Burden of Infectious Diseases in Kenya
B. Increased Awareness and Initiatives by Governmental and NGOs for Prevention
C. Rising Funding for Research and Development.
3. Major Infectious Diseases in Kenya…………………………………………………………
A. Malaria
B. Tuberculosis
D. Acute Respiratory Infections
E. Diarrhoea
F. Hepatitis
H. Cholera
I. Meningitis
J. Schistosomiasis
4. Infectious Disease Drug Market Segmentation……………………….
A. Drug Class
I. Anti-infectives
II. Corticosteroids
III. Vaccines
IV. Others
B. Causative Agents
I. Bacteria
II. Virus
III. Fungi
IV. Parasites
C. Distribution Channels
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
5. Infectious Diseases Major Products Market Share…………………………
A. Key Findings
B. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. GlaxoSmithKline Company overview, Product & Services, Strategies & Financials
B. Johnson & Johnson Company overview, Product & Services, Strategies & Financials
C. Novartis Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of Infectious Diseases drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Disease Type:

On the basis of disease type, the infectious diseases therapeutics market can be segmented into Malaria, HIV/AIDS, Tuberculosis, Hepatitis, Human Papilloma Virus (STDs), Meningitis, Cholera, Diarrhoea, Schistosomiasis, Acute Respiratory Diseases including Influenza, SARS and EBOLA and Zika virus.

By Causative Agents:

On the basis of causative agents, the infectious diseases therapeutics market can be segmented into Bacteria, Viruses, Fungi and Parasitic Micro-organisms and worms.

Tuberculosis and Meningitis are caused by bacterial infections, HIV/AIDS is caused by Human Immunodeficiency Virus and Malaria and Schistosomiasis is due to parasitic organism.

By Drug Class:

On the basis of drug class, the infectious disease therapeutics market can be segmented into anti-infectives, corticosteroids, vaccines and other drug classes.

Anti-Infectives segment include Anti-Biotics, Anti-Viral, Anti-Retroviral, Anti-Parasitic and Anti-Fungal drugs. This segment of drugs is expected to grow at an exponential rate during the forecasted period.

The only Vaccine approved for Malaria as of 2021 is RTS,S known by the brand name Mosquirix is manufactured by GlaxoSmithKline (GSK).

Vaccine for Tuberculosis is Bacille Calmette-Guerin (BCG) is widely used in Kenya as part of TB control Programme.

By Distribution Channels:

On the basis of distribution channels, the market is segmented into hospital pharmacies, retail and online pharmacies.

The Retail segment is expected to dominate the market throughout the forecast period.

Major Players

Many new players are emerging in the Infectious disease therapeutics market, as a result of a number of growth opportunities. The overall infectious diseases therapeutics industry is expected to witness tremendous growth, with several generic players controlling significant market share. Some of the companies which are currently dominating the market are GlaxoSmithKline (GSK), Novartis, Johnson & Johnson,, Merck & co. and Sanofi.

GlaxoSmithKline (GSK) is reported to be Kenya’s leading pharmaceutical supplier, with around 12% market share in 2018. GlaxoSmithKline has been able to garner a substantial share of Kenya’s pharmaceutical market largely due to the popularity of its anti-infectives. The prices of Amoxil (amoxicillin) 500mg, Suprapen (amoxicillin plus flucloxacillin) 500mg and Floxapen (flucloxacillin) 500mg are particularly competitive within the respective active ingredient classes.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements